Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2023

SuperCom Ltd. (NASDAQ: SPCB) Charting the Path for Digital Identity Solutions Adoption and Cybersecurity Advancement Globally

It is projected that by 2028, the Digital Identity Solutions (“DIS”) market will be valued at $83.2 billion, representing a CAGR of 19.3% over the forecast period (2023-2028). Experts have pointed out that this growth will be primarily driven by … Continue reading

Posted in SuperCom Ltd. SPCB | Leave a comment

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Publishes NI 43-101 Technical Report; Elaborates on Iska Iska Project’s Economic Potential

In early October 2019, Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company announced that it had signed a Letter of Intent, granting the company the option to acquire up to a 100% interest in the … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Solution for REE Extraction Could Disrupt Market

The race to stop climate change in its tracks by reducing industrial and motor vehicle pollutants has long been stymied, in part, by the difficulty of refining metals vital to modern, greener technology, but Canadian critical technology metals supply chain … Continue reading

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced

Renovaro Biosciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, recently announced a definitive agreement to combine with the advanced AI Company GEDiCube Intl Ltd., rebranding as Renovaro … Continue reading

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed CBD Proven Superior in Research

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track to submit an Investigational New Drug (“IND”) application for its planned U.S. Phase 1b Hypertension Clinical Trial HYPER H23-1. “Lexaria’s IND submission builds on five previous human … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Holds Live Investor Summit Webinar to Discuss Microgrid Deal with California Oil and Gas Company

Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, wrapped up a live investor summit webinar recently following the news that it had landed a major microgrid deal with one of California’s largest privately owned oil and gas corporations. According to the … Continue reading

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Announces Plans to Release Q3 2023 Financial Report, Host Corporate Update Call

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has announced plans to report its financial results for Q3 2023. The company will release the results on Nov. 10, 2023, before the market … Continue reading

Posted in Longeveron Inc. LGVN | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Featured in BTV Release Discussing Iska Iska MRE Results

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, has released the results from its recent Mineral Resource Estimate (“MRE”) for the Iska Iska deposit in southern Bolivia. Eloro Resources CEO and chair Thomas … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) PRV Sale Prospects Strengthened by Recent Industry Developments

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has set its sights on an exciting potential opportunity. With the engagement of Bourne Partners, a prominent financial services firm specializing in the pharmaceutical and consumer … Continue reading

Posted in PaxMedica Inc. PXMD | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Provides Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared an open letter to shareholders from CEO David Michery, providing updates on various matters and company initiatives. In the letter, Michery highlights several recent company accomplishments, including its … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment